Publications by authors named "Serge Mrejen"
Article Synopsis
- The study investigates the impact of the yellow fever vaccine (YFV) on patients with relapsing-remitting multiple sclerosis (RR-MS), who are generally advised against vaccination due to relapse risks.
- It utilized a non-interventional observational design, comparing relapse rates between 128 RR-MS patients who received YFV and those who did not.
- Findings indicate that there was no significant difference in annual relapse rates or time to first relapse between the two groups, suggesting YFV does not negatively affect RR-MS.
Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohort.
Neurol Neuroimmunol Neuroinflamm
December 2016
Objective: To assess disease activity within 12 months after natalizumab (NZ) discontinuation in a large French postmarketing cohort.
Methods: In France, patients exposed at least once to NZ were included in the TYSEDMUS observational and multicenter cohort, part of the French NZ Risk Management Plan. Clinical disease activity during the year following NZ discontinuation was assessed in this cohort.